Standard Anal Canal Cancer Treatment Preferred Over Experimental Drug
May 15th 2008Drug InformationColorectal Cancer
An article published in JAMA reports that forpatients with anal canal cancer, experimental chemotherapy treatmentwith the drug cisplatin (administered prior to othertreatments) failed to increase disease-free survival rates. Compared tothe standard treatment regimen, therapy with cisplatin also increasedthe likelihood of colostomy procedures.Commonly, the first treatment therapy for anal canal cancer ischemoradiation.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
